ArticleEuropean clinical respiratory journal2025
The prevalence and risk factors of respiratory symptoms in Finland: a comparative analysis.
Article in European clinical respiratory journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- JESREC score, metabolic factors, and pulmonary dysfunction: analysis among adult patients with chronic rhinosinusitis.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Knowledge about the local prevalence and risk factors of respiratory symptoms helps to address healthcare resources. Furthermore, no studies have compared the prevalence and risk factors of several respiratory symptoms within the same population. Objective: We conducted two cross-sectional email surveys in 2017 and 2021 for public service employees in two Finnish towns and Finnish Pensioners' Federation members. The questionnaires were sent to 40,185 subjects; 9,865 (24.6%) responded, 72.5% were female, and the mean age was 63 (range 18-94 years). Validated symptom questionnaires were included for each respiratory symptom. The questionnaire on sleep apnea symptoms was only included in the survey of retirees. Results: Prevalence of current asthma was 8.9%, wheezing with dyspnea 12.5%, chronic rhinosinusitis 11.9%, chronic cough 12.8%, TBQ phenotype cough 9.6%, chronic bronchitis 17.6% and gastroesophageal reflux symptoms 15.6%. In the retired group, the prevalence of sleep apnea symptoms was 32,8%. More than one respiratory symptom was present in 27.1% of subjects. A higher body mass index (BMI), smoking, and allergy increased the risk of most symptoms, while high household income protected against some symptoms. Increased age was associated with an increased risk of chronic cough, chronic bronchitis, and gastroesophageal reflux symptoms. In contrast, decreased age was associated with an increased risk of wheezing with dyspnea and chronic rhinosinusitis. The male gender increased the risk of chronic bronchitis and sleep apnea symptoms. All respiratory symptoms were associated with multiple non-respiratory symptoms. Conclusions: We gathered updated information on the prevalence of respiratory symptoms in Finland. Age, higher BMI, smoking, low household income, and allergy were significant risk factors for most respiratory symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.